Internal ophthalmoplegic migraine during pregnancy: a clinical case

datacite.rightshttp://purl.org/coar/access_right/c_abf2
dc.contributor.authorCastillo-Guerrero, Brenda
dc.contributor.authorLondoño-Juliao, Gloria
dc.contributor.authorpianetta, yesenia
dc.contributor.authorGutiérrez-Rey, Melissa
dc.contributor.authorZuñiga, Bley Jair
dc.contributor.authorPestana, Gustavo
dc.contributor.authorCarbonell-Zabaleta, Ana-Karina
dc.contributor.authorRivera-Porras, Diego
dc.contributor.authorBermudez, Valmore
dc.contributor.authorVARGAS MANOTAS, JOSE
dc.date.accessioned2025-12-05T14:41:26Z
dc.date.available2025-12-05T14:41:26Z
dc.date.issued2025
dc.description.abstractAbstract: Background: Ophthalmoplegic migraine (OM) is an uncommon variant of migraine characterised by headache and cranial nerve palsy, posing significant diagnostic and therapeutic challenges. Objective: This study aimed to describe an extremely rare OM variant with a partial therapeutic response. Clinical Case: A 34-year-old pregnant woman in gestational week 19.1 (G6P2A3) with a history of three consecutive spontaneous abortions presented at the emergency services with insidious onset and mild-to-moderate-intensity pulsatile bifrontal headache for 15 days, and the positional changes exacerbated this. At peak intensity, she experienced nausea, vomiting, tinnitus, and photophobia without phonophobia or osmophobia, prompting multiple visits to the emergency department. Despite a broad range of treatments, including intravenous fluids, analgesia, pericranial blocks, and preventive management, there was a non-significative improvement in the symptomatology described above. However, spontaneous resolution of this clinical picture was observed during the postpartum period. Results: This case highlights the complexity of ophthalmoplegic migraine, especially in the context of pregnancy, and raises questions about the underlying pathophysiological mechanisms. The absence of structural lesions on neuroimaging and postpartum resolution suggests a potential association with the hormonal and physiological changes associated with pregnancy. Conclusions: Despite limited scientific evidence, this report contributes to expanding the knowledge of this rare entity and emphasises the importance of a multidisciplinary approach to its management.eng
dc.format.mimetypepdf
dc.identifier.citationCastillo-Guerrero, B.; Londoño-Juliao, G.; Pianetta, Y.; Gutiérrez-Rey, M.; Zuñiga, B.J.; Pestana, G.; Carbonell-Zabaleta, A.-K.; Rivera-Porras, D.; Bermúdez, V.; Vargas-Manotas, J. Internal Ophthalmoplegic Migraine During Pregnancy: A Clinical Case. Neurol. Int. 2024, 16, 1779–1787. https://doi.org/10.3390/neurolint16060128eng
dc.identifier.doihttps://doi.org/10.3390/neurolint16060128
dc.identifier.issn20358377 (Electrónico)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/17170
dc.identifier.urlhttps://www.mdpi.com/2035-8377/16/6/128#
dc.language.isoeng
dc.publisherMDPIspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationaleng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceNeurology Internationaleng
dc.sourceNeurol. Int.eng
dc.sourceVol. 16 No. 6  Año 2024spa
dc.subject.keywordsOphthalmoplegic migraineeng
dc.subject.keywordsPregnancyeng
dc.subject.keywordsCephalalgiaeng
dc.subject.keywordsPersistent mydriasiseng
dc.subject.keywordsPaineng
dc.subject.keywordsCentral nervous systemeng
dc.titleInternal ophthalmoplegic migraine during pregnancy: a clinical casespa
dc.type.driverinfo:eu-repo/semantics/other
dc.type.spaOtros
dcterms.referencesKarsan, N. Pathophysiology of Migraine. Continuum 2024, 30, 325–343.eng
dcterms.referencesStovner, L.J.; Hagen, K.; Linde, M.; Steiner, T.J. The global prevalence of headache: An update, with analysis of the influences of methodological factors on prevalence estimates. J. Headache Pain 2022, 23, 34.eng
dcterms.referencesHernandez, J.; Molina, E.; Rodriguez, A.; Woodford, S.; Nguyen, A.; Parker, G.; Lucke-Wold, B. Headache Disorders: Differentiating Primary and Secondary Etiologies. J. Integr. Neurosci. 2024, 23, 43.eng
dcterms.referencesNegro, A.; Delaruelle, Z.; Ivanova, T.A.; Martelletti, P.; Mitsikostas, D.D.; Reuter, U.; Mitsikostas, D.D. Headache and pregnancy: A systematic review. J. Headache Pain 2017, 18, 106.eng
dcterms.referencesAshrafinia, F.; Kelley, E.L.; Meimand, H.E.; Iranmanesh, F.; Ghasemi, J.; Heydari, O. Headache characteristics in a sample of pregnant Iranian women with primary headache. SN Compr. Clin. Med. 2024, 6, 83.eng
dcterms.referencesFriedman, D. The ophthalmoplegic migraines: A proposed classification. Cephalalgia 2010, 30, 646–647.eng
dcterms.referencesNoruzzadeh, R.; Modabbernia, A.; Aghamollaii, V.; Ghaffarpour, M.; Harirchian, M.H.; Salahi, S.; Nikbakht, N.; Noruzi, N.; Tafakhori, A. Memantine for prophylactic treatment of migraine without aura: A randomised double-blind placebo-controlled study. Headache 2016, 56, 95–103.eng
dcterms.referencesAleksic, D.; Drakulic, S.; Ljubisavljevic, S. Recurrent Painful Ophthalmoplegic Neuropathy: Migraine, Neuralgia, or Something Else? J. Oral Facial Pain Headache 2020, 34, 374–378.eng
dcterms.referencesSorsby-Vargas, A.M.; Martínez-Maldonado, A.; Arellano-Martínez, C.L. Migraña oftalmopléjica con oftalmoplejia interna bilateral. Reporte de un caso. Rev. Mex. Oftalmol. 2022, 96, 93–97.spa
dcterms.referencesD’Ippolito, S.; Barbaro, G.; Paciullo, C.; Tersigni, C.; Scambia, G.; Di Simone, N. Antiphospholipid syndrome in pregnancy: New and old pathogenetic mechanisms. Int. J. Mol. Sci. 2023, 24, 3195.eng
dcterms.referencesLeal Rato, M.; Bandeira, M.; Romão, V.C.; Aguiar de Sousa, D. Neurologic Manifestations of the Antiphospholipid Syndrome—An Update. Curr. Neurol. Neurosci. Rep. 2021, 21, 41.eng
dcterms.referencesSherer, Y.; Hassin, S.; Shoenfeld, Y.; Levy, Y.; Livneh, A.; Ohry, A.; Langevitz, P. Transverse myelitis in patients with antiphospholipid antibodies--the importance of early diagnosis and treatment. Clin. Rheumatol. 2002, 21, 207–210.eng
dcterms.referencesCervera, R.; Boffa, M.C.; Khamashta, M.A.; Hughes, G.R.V. The Euro-Phospholipid project: Epidemiology of the antiphospholipid syndrome in Europe. Lupus 2009, 18, 889–893.eng
dcterms.referencesAndreoli, L.; Chighizola, C.B.; Banzato, A.; Pons-Estel, G.J.; Ramire de Jesus, G.; Erkan, D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature. Arthritis Care Res. 2013, 65, 1869–1873.eng
dcterms.referencesde Carvalho, J.F.; Pasoto, S.G.; Appenzeller, S. Seizures in Primary Antiphospholipid Syndrome: The Relevance of Smoking to Stroke. Clin. Dev. Immunol. 2012, 2012, 981519.eng
dcterms.referencesYelnik, C.M.; Kozora, E.; Appenzeller, S. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome. Curr. Rheumatol. Rep. 2016, 18, 11.eng
dcterms.referencesOrzechowski, N.M.; Wolanskyj, A.P.; Ahlskog, J.E.; Kumar, N.; Moder, K.G. Antiphospholipid antibody-associated chorea. J. Rheumatol. 2008, 35, 2165–2170.eng
dcterms.referencesD’Angelo, C.; Franch, O.; Fernández-Paredes, L.; Oreja-Guevara, C.; Núñez-Beltrán, M.; Comins-Boo, A.; Reale, M.; Sánchez- Ramón, S. Antiphospholipid antibodies overlapping in isolated neurological syndrome and multiple sclerosis: Neurobiological insights and diagnostic challenges. Front. Cell. Neurosci. 2019, 13, 107.eng
dcterms.referencesJeruc, J.; Popovic, M.; Vizjak, A.; Jurci´c, V.; Lestan, B.; Ferluga, D. Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: A case report. Folia Neuropathol. 2006, 44, 140–143.eng
dcterms.referencesCavestro, C.; Micca, G.; Molinari, F.; Bazzan, M.; DI Pietrantonj, C.; Aloi, R.; Pedemonte, E.; Iannini, R.; Frigeri, M.C.; Roccatello, D. Migraineurs show a high prevalence of antiphospholipid antibodies. J. Thromb. Haemost. 2011, 9, 1350–1354.eng
dcterms.referencesSchürks, M.; Rist, P.M.; Bigal, M.E.; Buring, J.E.; Lipton, R.B.; Kurth, T. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ 2009, 339, b3914.eng
dcterms.referencesIslam, M.A.; Alam, F.; Wong, K.K. Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis. Autoimmun. Rev. 2017, 16, 512–522.eng
dcterms.referencesGrygiel-Górniak, B.; Rogacka, N.; Puszczewicz,M. Antinuclear antibodies in healthy people and non-rheumatic diseases—Diagnostic and clinical implications. Reumatologia 2018, 56, 243–248.eng
dcterms.referencesKavanaugh, A.; Tomar, R.; Reveille, J.; Solomon, D.H.; Homburger, H.A. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch. Pathol. Lab. Med. 2000, 124, 71–81.eng
dcterms.referencesStinton, L.M.; Eystathioy, T.; Selak, S.; Chan, E.K.; Fritzler, M.J. Autoantibodies to protein transport and messenger RNA processing pathways: Endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin. Immunol. 2004, 110, 30–44.eng
dcterms.referencesRau, J.C.; Dodick, D.W. Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists. Curr. Treat. Options Neurol. 2019, 21, 17.eng
dcterms.referencesDrugs.com. Memantine: Pregnancy Warnings. Available online: https://www.drugs.com/pregnancy/memantine.html# pregnancy-warnings (accessed on 15 August 2022).eng
dcterms.referencesMacGregor, E.A. Headache in pregnancy. Neurol. Clin. 2012, 30, 835–866.eng
dcterms.referencesMarkey, K.A.; Mollan, S.P.; Jensen, R.H.; Sinclair, A.J. Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurol. 2016, 15, 78–91.eng
dcterms.referencesNan, L.; Yang, X.G.; Lian, X.; Feng, Y.H.; Li, C.P.; Ma, H.C. Full-term pregnant women have higher lumbar epidural pressure than non-pregnant women: A preliminary report. J. Obstet. Gynaecol. 2013, 33, 50–53.eng
oaire.versioninfo:eu-repo/semantics/publishedVersion
sb.programaEspecialización en Neurologíaspa
sb.sedeSede Barranquillaspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
6.08 MB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.93 KB
Formato:
Item-specific license agreed upon to submission
Descripción: